X0306 4 2022-04-30 0 0001596946 Quotient Ltd QTNT 0001056630 SHROFF ZUBEEN C/O GALEN PARTNERS, 680 WASHINGTON BLVD STAMFORD CT 06901 1 0 0 0 Ordinary Shares 7329074 I See footnote Ordinary Shares 2022-04-30 4 M 0 13538 A 118461 D Ordinary Shares Option (Right to buy) 11.62 2025-10-31 Ordinary Shares 7505 7505 D Ordinary Shares Option (Right to buy) 8.00 2024-04-29 Ordinary Shares 5000 5000 D Ordinary Shares Option (Right to buy) 9.95 2024-10-31 Ordinary Shares 5025 5025 D Ordinary Shares Option (Right to buy) 5.73 2026-10-31 Ordinary Shares 8726 8726 D Ordinary Shares Option (Right to buy) 5.21 2027-10-31 Ordinary Shares 9597 9597 D Ordinary Shares Option (Right to buy) 6.41 2028-10-31 Ordinary Shares 6240 6240 D Ordinary Shares Option (Right to buy) 7.78 2029-10-31 Ordinary Shares 8158 8158 D Ordinary Shares Option (Right to buy) 4.55 2030-10-31 Ordinary Shares 13611 13611 D Restricted Stock Units 2022-04-30 4 M 0 10870 0.00 D Ordinary Shares 10870 21738 D Restricted Stock Units 2022-04-30 4 M 0 2668 0.00 D Ordinary Shares 2668 5336 D Ordinary Shares Option (Right to buy) 2.53 2031-10-31 Ordinary Shares 24040 24040 D Restricted Stock Units convert into ordinary shares on a one-for-one basis. Includes 6,613,590 ordinary shares held of record by Galen V, 564,780 ordinary shares held by Galen International V, and 150,704 ordinary shares held of record by Galen Management, LLC. Mr. Shroff is a managing director of Galen Management, LLC, and shares voting and dispositive power over the securities held by Galen V, Galen International V and Galen Management, LLC. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein. All 7,505 options have vested and remain exercisable. All 5,000 options have vested and remain exercisable. All 5,025 options have vested and remain exercisable. All 8,726 options have vested and remain exercisable. All 9,597 options have vested and remain exercisable. All 6,240 options have vested and remain exercisable. 2,719 options vested on October 31, 2021 and remain exercisable, and the remaining 2,720 options will vest on October 31, 2022. All 13,611 options have vested and remain exercisable. On October 31, 2021, the Reporting Person was granted 43,478 restricted stock units, of which 21,704 have vested and have converted into ordinary shares. The remaining 21,738 restricted stock units will vest in two equal installments on July 31, 2022 and October 31, 2022. On October 31, 2021, the Reporting Person was granted 10,672 restricted stock units, of which 5,336 have vested and have converted into ordinary shares. The remaining 5,336 restricted stock units will vest in two equal installments on July 31, 2022 and October 31, 2022. The options vest and become exercisable on October 31, 2022. /s/ Zubeen Shroff 2022-05-03